BiO2 Medical Executes Full Commercialization in the United Kingdom Partnering with United Drug Medical (UDM) as an Exclusive Distributor for the Angel® Catheter
BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, has signed a distribution agreement with Pyramed, a division of United Drug Medical (UDM). This milestone accomplishment grants Pyramed exclusive rights to distribute the Angel® Catheter throughout ...
BiO2 Medical Executes Q4 2013 Commercialization Strategy for the Angel® Catheter, Signing Distribution Partnership Agreements in Key European and Middle Eastern Geographies
BiO2 Medical has achieved Q4 2013 global expansion goals for the Angel® Catheter, a novel Central Venous Catheter (CVC) with a permanently attached retrievable Inferior Vena Cava (IVC) filter to provide Pulmonary Embolism (PE) protection for critically ill patients. The Angel® Catheter is the first ...
Partnership offers BiO2 Medical a hydrophilic and lubricious coating to enhance ease of placement and reduce access site trauma for the Angel® Catheter, a central venous access catheter (CVC) with a permanently attached inferior vena cava (IVC) filter. DSM a global leader in biomedical materials ...
BiO2 Medical Inc. Prophylactic Pulmonary Embolism Protection Hospitalized patients are at the greatest risk for a fatal pulmonary embolism within the first 10 days after admission, but traditional inferior vena cava filters to prevent PEs if anticoagulant therapy is contraindicated and/or ineffective are not typically placed in ...